EUVIMEDObjevte EUVIMED
Randomisierte kontrollierte StudieMultizentrische StudiePragmatische StudieOpen access · CC BY 4.0

Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial

Jinshuo Li iD, Qi Wu iD, Steve Parrott, Ian Pope, Lucy V Clark, Allan Clark, Emma Ward iD, Pippa Belderson, Susan Stirling, Timothy J Coats, Linda Bauld, Richard Holland and 8 more

Addiction · 2025

DOI: 10.1111/add.16698 ↗

At a glance

Randomisierte kontrollierte Studie in Addiction, 2025. Written by Jinshuo Li and 19 co-authors. Institution: Department of Health Sciences, University of York, York, UK. Major MEDLINE topics: Cost-Benefit Analysis, Smoking Cessation, Emergency Service, Hospital, Electronic Nicotine Delivery Systems. Cited 6 times so far (Crossref); 47 references. The full text is freely available (open access, CC BY 4.0). Funded by: NIHR Health Technology Assessment Programme, Health Technology Assessment Programme.

AbstraktSubjectsBibliografické údajeCiteRelated studies

Abstract (original language)

Aims

To assess the cost‐effectiveness of the Cessation of Smoking Trial in Emergency Department (COSTED) intervention compared with signposting to local stop smoking service (SSS) from the National Health Service (NHS) and personal social services (PSS) perspective. Design, setting and participants This was a two‐group, multi‐centre, pragmatic, individually randomized controlled trial set in six Emergency Departments (EDs) in urban and rural areas in the United Kingdom. Adult (≥ 18 years) daily smokers (at least one cigarette or equivalent per day) but not daily e‐cigarette users, with carbon monoxide reading ≥ 8 parts per million, attending the ED ( n = 972) were included. The intervention consisted of provision of an e‐cigarette starter kit plus brief smoking cessation advice and referral to a local SSS. Control was an information card on how to access local SSS.

Measurements

Intervention costs included costs of training and delivery. Control costs included costs of printing information cards. Costs of smoking cessation and health‐care services were estimated based on quantities reported by participants and unit costs extracted from secondary sources. The effects were measured by quality‐adjusted life years (QALYs) derived from EQ‐5D‐5L. Other outcomes were smoking cessation measures. The primary outcome was incremental cost‐effectiveness ratio (ICER), which was calculated by dividing the difference in costs by the difference in QALYs between groups.

Findings

The mean intervention costs were £48 [standard error (SE) = £0] per participant and the mean control costs were £0.2 (SE = £0) per participant. Using regression estimates, total costs were £31 [95% confidence interval (CI) = –£341 to £283] higher and 6‐month QALYs were 0.004 (95% CI = –0.004 to 0.014) higher in the intervention group than in the control group. The ICER was calculated at £7750 (probability of cost‐effective at range £20 000–30 000: 72.2–76.5%).

Conclusions

The UK Cessation of Smoking Trial in Emergency Department (COSTED) intervention (provision of an e‐cigarette starter kit plus brief smoking cessation advice) was cost‐effective compared with signposting to local stop smoking services under the current recommendations of the maximum acceptable thresholds.

Subjects

MeSH terms (MEDLINE)

Cost-Benefit AnalysisSmoking CessationEmergency Service, HospitalElectronic Nicotine Delivery SystemsHumansMaleAdultFemaleUnited KingdomMiddle AgedQuality-Adjusted Life YearsState Medicine

Author keywords

Brief interventionMarkov modelcost‐effectivenesseconomic evaluationemergency departmente‐cigarettelife‐time modellingrandomized controlled trialsmoking cessation

Authors and institutions

  • Department of Health Sciences, University of York, York, UK.
  • Norfolk and Norwich University Hospital, Norwich, UK.
  • Norwich Clinical Trials Unit, Norwich Medical School, University of East Anglia, Norwich, UK.
  • Norwich Medical School, University of East Anglia, Norwich, UK.
  • Department of Cardiovascular Sciences, University of Leicester, Leicester, UK.
  • Usher Institute and SPECTRUM Consortium, College of Medicine, University of Edinburgh, UK.

ORCID profiles: Jinshuo Li, Qi Wu, Emma Ward, Sarah Gentry, Jonathan Livingstone-Banks, Caitlin Notley

Funding

  • NIHR Health Technology Assessment Programme
  • Health Technology Assessment Programme

Cite

APA

Li, J., Wu, Q., Parrott, S., Pope, I., Clark, L. V., Clark, A., Ward, E., Belderson, P., Stirling, S., Coats, T. J., Bauld, L., Holland, R., Gentry, S., Agrawal, S., Bloom, B. M., Boyle, A., Gray, A., Morris, M. G., Livingstone-Banks, J., & Notley, C. (2025). Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial. Addiction. https://doi.org/10.1111/add.16698

Vancouver

Li J, Wu Q, Parrott S, Pope I, Clark LV, Clark A, et al. Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial. Addiction. 2025. doi:10.1111/add.16698

BibTeX
@article{Li2025,
  author = {Li, Jinshuo and Wu, Qi and Parrott, Steve and Pope, Ian and Clark, Lucy V and Clark, Allan and Ward, Emma and Belderson, Pippa and Stirling, Susan and Coats, Timothy J and Bauld, Linda and Holland, Richard and Gentry, Sarah and Agrawal, Sanjay and Bloom, Benjamin M and Boyle, Adrian and Gray, Alasdair and Morris, M Geraint and Livingstone-Banks, Jonathan and Notley, Caitlin},
  title = {Cost–utility analysis of provision of e‐cigarette starter kits for smoking cessation in emergency departments: An economic evaluation of a randomized controlled trial},
  journal = {Addiction},
  year = {2025},
  doi = {10.1111/add.16698}
}
Start for free →